hypericum perforatum phytoplacenta culture extract é seguro durante a gravidez?
No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
Related ingredients
Frequently asked questions
- hypericum perforatum phytoplacenta culture extract é seguro durante a gravidez?
- No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion specifically flagging 'Hypericum perforatum phytoplacenta culture extract' as a reproductive hazard; published literature on Hypericum shows pharmacological/systemic effects when taken orally but no confirmed teratogenicity that would trigger H360/H361 classification. Topical cosmetic use is expected to give low but measurable systemic exposure in adults (so exposure score 1). Sources considered: ECHA Annex VI (no harmonised classification for this ingredient), CIR (no specific adverse reproductive finding for cosmetic extracts of Hypericum), PubMed literature on Hypericum pharmacology.
- hypericum perforatum phytoplacenta culture extract é seguro durante a amamentação?
- No authoritative safety assessment (CIR/SCCS/ECHA harmonised CLP) identifies this ingredient as a lactation/milk transfer reproductive hazard. Systemic absorption from topical use is expected to be low but not zero, so maternal exposure and potential minimal transfer to milk are possible but not demonstrated for this extract. Sources: PubMed literature on Hypericum systemic use (shows oral systemic effects rather than topical), CosIng/ECHA (no lactation-specific classification).
- hypericum perforatum phytoplacenta culture extract é seguro para a pele do bebê?
- No evidence of infant-specific reproductive or developmental toxicity for this ingredient in authoritative sources; therefore hazard and mechanism scores default to 0. Because infant skin has higher absorption and surface-area-to-weight ratio, exposure score is increased by +1 relative to adult topical use (adult e=1 → infant e=2). Note: photosensitizing constituents of Hypericum (hypericin) could be relevant for topical use on infants, but reproductive/endocrine effects in infants are not documented. Sources: general Hypericum literature (PubMed), CosIng/ECHA (no infant-specific safety findings).
- Como o VeriMom pontua hypericum perforatum phytoplacenta culture extract?
- O VeriMom pontua hypericum perforatum phytoplacenta culture extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a hypericum perforatum phytoplacenta culture extract na gravidez?
- Veja nossa lista curada de alternativas seguras a hypericum perforatum phytoplacenta culture extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.